Bayer

General

FDA Gives Green Light to Bayer’s Ambelvist for Enhanced MRI Imaging

The FDA has approved Bayer’s Ambelvist, a contrast agent for enhanced MRI imaging, marking a significant advancement in medical diagnostics. This approval is expected to improve patient outcomes by providing sharper images and more accurate diagnoses. The development underscores the FDA’s commitment to medical innovation and marks a major breakthrough for Bayer.

FDA Gives Green Light to Bayer’s Ambelvist for Enhanced MRI Imaging Read Post »

General

Bayer Taps New Leader to Head Radiology Business

Bayer has appointed a new president to lead its radiology business, driving growth and innovation in medical imaging technologies. The move strengthens Bayer’s position in the healthcare market, with a focus on delivering innovative solutions that improve patient outcomes. The new president brings extensive experience in the medical imaging industry, poised to build on Bayer’s existing portfolio of radiology products and services.

Bayer Taps New Leader to Head Radiology Business Read Post »

Scroll to Top